February 9, 2017 - Polyphor receives CHF 2.3 Million Award from Wellcome Trust
December 12, 2016 - Polyphor achieves milestone in Taisho collaboration
December 7, 2016 - Polyphor achieves milestone and extends R&D collaboration
October 18, 2016 - Giacomo Di Nepi Appointed New CEO of Polyphor
December 22, 2015 - Polyphor and Boehringer Ingelheim extend macrocyle R&D collaboration.
December 1, 2015 – Polyphor announces extension of R&D collaboration.
September 17, 2015 – Polyphor and Taisho enter into research collaboration on novel drug candidates.
September 15, 2015 – Polyphor is nominated for the Prix SVC Nordschweiz.
March 17, 2015 – Polyphor appoints new CEO and strengthens executive management team.
November 4, 2013 – Polyphor and Roche join efforts to combat multidrug-resistant bacterial infections. German translation. French translation.
July 31, 2013 – Polyphor achieves first milestone in MacroFinder® collaboration with Boehringer Ingelheim.
June 11, 2013 – Polyphor attracts senior Pharma professionals to strengthen its Board of Directors.
March 4, 2013 – Polyphor announces successful Phase I results for its Pseudomonas selective antibiotic POL7080.
June 12, 2012 – Polyphor and Boehringer Ingelheim announce MacroFinder® collaboration.
July 27, 2011 - Polyphor and Axxam announce EU funded R&D collaboration for the treatment of Type-2 Diabetes.
May 6, 2010 - Polyphor and Novartis announce PEMfinder® collaboration.
April 12, 2010 - Polyphor and Axxam SpA announce ion channel collaboration.
February 19, 2010 - Polyphor discovers a new class of antibiotics with a novel mode of action. New weapon in the fight against multi-drug resistant bacteria published in “Science” (click here for German version).